AxiomBio at ACT 2026

Nov 15–18, 2026 San Antonio, TX ~1.4k attendees Website

AxiomBio takes part in 1 session at ACT 2026 in San Antonio, and exhibits at Booth 110. Its program centres on human cell models of liver injury, showing how profiling human liver cells in several ways at once can separate drugs that injure the liver by different mechanisms within the same therapeutic class.

OrganizationACT 2026 Attendance
AxiomBio
San Francisco, CA
axi.om
Software and AI companies
Builds AI models that predict drug toxicity, including liver injury, from human cell data instead of animal studies.
Booth
Exhibiting at Booth 110
Mon, Nov 169:30am–6:30pmTue, Nov 178:00am–4:30pm
Poster
Mon Nov 16
5:00pm–6:30pm

Explore the full ACT 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in San Antonio. Leave your work email and we’ll be in touch.

Privacy

Download the full ACT 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from AxiomBio

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by the American College of Toxicology (ACT). Organization details are derived from ACT’s published program, exhibitor floor plan and supporter list, and each organization’s own website. Submit a correction